CANDRIAM S.C.A. – Xenon Pharmaceuticals Inc. Transaction History
CANDRIAM S.C.A. portfolio value:
$27.46M
portfolio value
CANDRIAM S.C.A. quarter portfolio value change:
+18.67%
quarter
Xenon Pharmaceuticals Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -11.85% | -102.25K shares | 1.21M | $36.1 | 760.88K |
| Q2 2022 | share | Increase | +42.84% | 258.88K shares | 7.78M | $30.42 | 863.14K |
| Q1 2022 | share | Increase | +13.90% | 73.74K shares | 1.89M | $30.57 | 604.25K |
| Q4 2021 | share | Decrease | -25.88% | -185.21K shares | 5.63M | $31.99 | 530.51K |
| Q3 2021 | share | 0.00% | 0 shares | -2.39M | $15.28 | 715.72K | |
| Q2 2021 | share | Increase | 0.00% | 715.72K shares | 13.32M | $18.62 | 715.72K |